Cellular Health Screening Market Size & Share, by Type (Single-test Panels, Telomere Tests, Oxidative Stress Tests, Inflammation Tests, Heavy Metals Tests, and Multi-test Panels); Sample (Blood, Saliva, Serum, Urine); Collection Site (Home, Office, Hospital, Diagnostic Labs) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 1379
  • Published Date: Oct 11, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Cellular Health Screening Market size is predicted to surpass USD 93 billion by the end of 2035, expanding around 10% CAGR during the forecast period i.e., 2024-2036. In the year 2023, the industry size of cellular health screening was over USD 13 billion. The growth of this market can be primarily driven by the increasing prevalence of cancer all over the world. In 2022, in the United States around 1.9 cancer cases were reported and 609,360 people lost their lives due to cancer. In order to offer proper treatment on time cell analyzing aids in the detection of malignancies before they spread in the whole body. The detection of malignancies before the visibility of symptoms is possible with the aid of cell health screening.

The rising use of cellular health screening in customized medicine and the government's increased emphasis on preventative care are both responsible for the market's expansion. For market participants in this industry, the potential uses of cellular health screening in customized medicine have created tremendous growth potential. In prostate cancer and breast cancer cells grown in the lab, researchers were able to inhibit telomerase activity, leading to tumor growth.

Cellular Health Screening Market
Get more information on this report: Request Free Sample PDF

Cellular Health Screening Market: Key Insights

Base Year


Forecast Year

2024 – 2036



Base Year Market Size

~USD 13 billion

Forecast Year Market Size

~USD 93 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Cellular Health Screening Sector: Growth Drivers and Challenges


Growth Drivers

  • Demand for Testing Solutions Based on Preventive Healthcare - A rise in outreach efforts by organizations worldwide has increased the necessity for evaluating preventative healthcare-based solutions. Collaboration efforts performed by organizations like the WHO, CDC, U.S. Preventive Services Task Force, and National Cervical Cancer Coalition to encourage cervical cancer screening are one of the major key aspects expected to push cellular health screening market expansion in the near future.
  • Growing Incidence of Chronic Diseases - Numerous studies have demonstrated a relationship between telomere length and malignancies. In cancer that has advanced more severely, a decrease in telomere length as a form of tumor suppressor comes out to be a key impact. Telomere length has been shown to be influenced by a variety of factors, including infections, inflammation, and stress. Inflammation, in particular, induces oxidative stress, which leads to telomere erosion. According to studies, telomere maintenance has a substantial impact on how environmental, habits and genetic variables influence aging and related illnesses. In order to comprehend biological aging and genetic diseases, it is necessary to grasp how quickly telomeres change. In addition, telomere shortening has been associated with aging-related diseases such as cancer, cardiovascular disease and weakened immune systems.
  • Growing Awareness Among Population Regarding the Benefits of Preventive Healthcare – The growth of this market is also driven by the growing awareness among the population regarding the importance and benefits of preventive healthcare. This further is giving rise to consumer interest and growing adoption of cellular health screening all across the globe. Additionally, the use of these tools enhances timely treatment decisions, boosts the efficacy of care provided, and significantly reduces diagnosis costs, particularly in resource-constrained nations with subpar laboratory facilities. 


  • Data Privacy and Security – Cellular health screening tests collect sensitive personal health data. There is a risk that this data could be breached or misused, which could have negative consequences for patients. Cellular health screening companies need to comply with all applicable data privacy laws and regulations. This comprises of laws such as the General Data Protection Regulations in the European Union and the California Consumer Privacy Act in the United States. This is set to hamper the market expansion in the upcoming period.
  • Lack of Standardization is Estimated to Hamper the Market Expansion in the Forecast Period.
  • Limited Accessibility Issues are Predicted to Restrict Market Growth in the Future Times.

Cellular Health Screening Segmentation

Sample (Blood, Saliva, Serum, Urine)

Cellular health screening market from the blood sample segment is slated to hold 40% of the revenue share by 2036. The factors contributing to this segment's growth are a high incidence of blood sample use by physicians, as well as the application of diagnostic kits for the assessment of different disease conditions, organ function, and risk factor analysis. Also, market growth is being stimulated by the launch of new diagnostic devices that use blood to detect and screen. In the case of Osler, for example, a blood test company that's raising funding before it gets ready to launch its diagnostics device. The new technology will give you a result in less than 10 minutes and it wants to provide cheap blood tests.

Collection Site (Home, Office, Hospital, Diagnostic Labs)

The home segment in the cellular health screening market is poised to grow substantially during the forecast period. This is explained by rising health consciousness and widespread use of self-sampling in important marketplaces. Self-sampling has become popular because it is simple to use and doesn't call for specialized equipment or qualified personnel. Additionally, the COVID-19 epidemic resulted in a widespread choice for home collections because of the restrictions on movement, and this choice will persist for years to come. For instance, Lab Corp declared in April 2022 that it had begun offering home collection services for the company's range of diagnostic and examination offers.

Our in-depth analysis of the global market includes the following segments:


  • Single-test Panels
  • Telomere Tests
  • Oxidative Stress Tests
  • Inflammation Tests
  • Heavy Metals Tests
  • Multi-test Panels


  • Blood
  • Saliva
  • Serum
  • Urine

     Collection Site

  • Home
  • Office
  • Hospital
  • Diagnostic Labs

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Cellular Health Screening Industry: Regional Synopsis

North American Market Forecasts

The North America region is set to hold 33% share of the global cellular health screening market by 2036. The growth of this market can be attributed on the back of increasing awareness about personalized medicines, growing government initiatives supporting preventive healthcare, and growing adoption of new technologies. Besides this robust expansion of healthcare infrastructure in the North America region is estimated to boost the market growth of cellular health screening in this region during the projection period. In June 2021, Grail launched a unique blood test capable of detecting the presence of multiple cancers using the Galleri diagnostic method. This test is intended to screen people at high risk of cancer, such as adults over 50 years old. Such initiatives by major players in the market are leading to increased adoption of cellular health screening in the region, thereby driving market growth.

Asia Pacific Market Statistics

The cellular health screening market in the Asia Pacific is estimated to hold a substantial growth during the forecast timeframe. The increase in the number of people, which is contributing to a large patient pool and creating an infrastructure for health care due to increased economic activity, accounts for this. The key drivers for growth in the Asia Pacific region include improved adoption of tests and awareness by adults about their health. Regional growth is also supported by higher research on telomere senescence, as well as public policies aimed at preventing diseases.

Research Nester
Cellular Health Screening Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Cellular Health Screening Landscape

    • SpectraCell Laboratories Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Genova Diagnostics
    • Immundiagnostik AG
    • Quest Diagnostics
    • Bio-Reference Laboratories Inc.
    • Bloom Diagnostics
    • Cell Science System Corporation
    • Laboratory Corporation of American Holdings


In The News

  • Bloom Diagnostics announced the introduction of the new Bloom Inflammation Test, which measures C-reactive protein (CRP) in the blood to detect inflammation in the body.
  • QIAGEN NV launched QIAstat Dx Rise and innovative panels. The QIA stat-Dx Rise and its test cartridges provide a self-contained system for easy sample preparation and processing.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 1379
  • Published Date: Oct 11, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing prevalence of cancer and growing demand for personalized medicines are some of the major factors anticipated to drive the growth of the cellular health screening market.

The market is anticipated to attain a CAGR of ~10% over the forecast period, i.e., 2024-2036.

The major players in the market are of Quest Diagnostics, Bio-Reference Laboratories Inc., QIAGEN NV, Bloom Diagnostics, Cell Science System Corporation, Laboratory Corporation of American Holdings, and others.

The hospital segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in North America is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Cellular Health Screening Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying